Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)
Phase 1
Completed
- Conditions
- COVID-19 Vaccine Adverse ReactionCOVID-19 Infection
- Interventions
- Biological: Placebo
- First Posted Date
- 2023-09-11
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Lemonex
- Target Recruit Count
- 20
- Registration Number
- NCT06032000
- Locations
- 🇰🇷
Seoul National University Hospital Clinical Trials Center, Seoul, Korea, Republic of
News
No news found